DempoChem Logo
  1. HomeHome
  2. /ProductsProducts
  3. /Bioactive CompoundsBioactive Compounds
  4. /Anti-Infective AgentsAnti-Infective Agents
  5. /Antibacterial AgentsAntibacterial Agents
  6. /PradofloxacinPradofloxacin
Chemical structure of CAS 195532-12-8

Pradofloxacin

In Stock•Starting at $93 for 5 mg•Purity ≥ 97%
CAS No.195532-12-8
MDL No.N/A
MFC21H21FN4O3
MW396.40
InChI KeyLZLXHGFNOWILIY-APPDUMDISA-N
CUSTOM SYNTHESISPRECLINICAL SUPPORT→

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
5 mg97%$93In Stock
10 mg97%$148In Stock
25 mg97%$291In Stock
50 mg97%$580In Stock
100 mg97%$1156In Stock
Custom synthesis and bulk supply options are available upon request.

Product Information

CAS No.195532-12-8
Product NamePradofloxacin
IrritantIrritant
Health HazardHealth Hazard
Signal Word:Warning
HCode:H302-H341
PCode:P203-P264-P270-P280-P301+P317-P318-P330-P405-P501

Related Articles

Studies related to this compound and its mechanism of action

Retinal safety of a new fluoroquinolone, pradofloxacin, in cats: assessment with electroretinography.

Documenta ophthalmologica. Advances in ophthalmology • Vol. 116, Issue 3 • 2008
PMID: 17909874DOI: 10.1007/s10633-007-9081-x

Efficacy of pradofloxacin in cats with feline upper respiratory tract disease due to Chlamydophila felis or Mycoplasma infections.

Journal of veterinary internal medicine • Vol. 22, Issue 1 • 2008
PMID: 18289288DOI: 10.1111/j.1939-1676.2007.0012.x

Pharmacokinetics of pradofloxacin and doxycycline in serum, saliva, and tear fluid of cats after oral administration.

Journal of veterinary pharmacology and therapeutics • Vol. 31, Issue 2 • 2008
PMID: 18307499DOI: 10.1111/j.1365-2885.2007.00932.x

Comparative activity of pradofloxacin against anaerobic bacteria isolated from dogs and cats.

The Journal of antimicrobial chemotherapy • Vol. 60, Issue 5 • 2007
PMID: 17872918DOI: 10.1093/jac/dkm346

Documentation

Similar Products

  • Moxifloxacin

    CAS No.151096-09-2

  • Moxifloxacin Hydrochloride

    CAS No.186826-86-8

  • Moxifloxacin hydrochloride monohydrate

    CAS No.192927-63-2

  • Finafloxacin

    CAS No.209342-40-5

  • Finafloxacin hydrochloride

    CAS No.209342-41-6

Your Partner for
Complex Chemistry
logo
  • About Us
  • Perspectives
  • Products
  • Contact
  • Preclinical Development
  • Technologies
  • Custom Synthesis
Ready to start your project?

Provide your target molecule or project specifications to align on a tailored development and scale-up pathway with our scientific team.

START A PROJECT
Westerstraat 10, 3016 DH, Rotterdam, The Netherlands
Westerstraat 10, 3016 DH, Rotterdam, The Netherlands
logo

All products are supplied strictly for research and development use only and are not intended for human or veterinary administration, diagnostic use, or therapeutic use. Preclinical and related services are provided solely for research and development purposes and do not constitute clinical diagnosis, treatment, or veterinary care.

©2026 DempoChem. All Rights Reserved.
DHLFedExUPSPostNL
CLIENT PORTAL|TERMS AND CONDITIONS|PRIVACY POLICY|
  • Products
    • CDMO Compounds
    • API & Candidates
  • Services
    CDMO & Manufacturing
    • Custom Synthesis
    • Process Development
    • Lab To Pilot
    • Commercialization
    • Generic APIs
    CRO
    • Preclinical
    • Pharmacology & Efficacy
    • DMPK & Bioanalysis
    • Toxicology & Safety
    • Disease Models
    Technologies
    • High-Potent
    • Chiral Synthesis
    • Cloud Synthesis
    • Fermentation
    • Flow Chemistry
    • Biocatalysis
    Support
    • Regulatory Support
    • Supply Chain Solutions
  • About
  • Perspectives
  • Contact